INDP
Indaptus Therapeutics, Inc. (INDP) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
No disclosed environmental intensity metrics are provided, leaving peer-relative assessment constrained versus industrial peers with more transparent emissions and energy data.
The absence of reported R&D spend suggests limited evidence of environmental innovation, while peers with cleaner-process investment may show stronger transition positioning.
Zero disclosed stock-based compensation does not directly affect environmental performance, but the limited metric set reduces visibility into climate governance and accountability.
Net debt to EBITDA is modest at 0.49x, which can support environmental capex flexibility, though peers with stronger balance sheets may sustain larger decarbonization programs.
Social
No workforce, safety, turnover, or community metrics are provided, so social positioning cannot be verified against peers with fuller disclosure.
The lack of disclosed employee incentive intensity limits evidence of retention alignment, while peers with clearer human-capital metrics may appear stronger.
Zero stock-based compensation reduces dilution concerns, but it also offers little insight into long-term employee ownership or social alignment versus peers.
With no reported social controversy data, the profile appears neutral, yet peers with audited labor and safety disclosures likely hold an informational advantage.
Governance
Debt-to-equity is reported at zero and net debt to EBITDA at 0.49x, indicating conservative leverage versus more indebted peers and lower governance stress.
Zero stock-based compensation suggests restrained equity dilution, though peers with explicit long-term incentive disclosure may demonstrate stronger pay transparency.
The absence of disclosed R&D and profitability metrics limits board-level visibility into capital allocation discipline relative to peers with richer governance reporting.
No controversy or control-structure information is provided, so governance appears acceptable but not demonstrably stronger than peers with more complete disclosure.
Overall Score
INDP appears broadly in line with peers on ESG based on limited disclosure, with modest balance-sheet conservatism offset by weak transparency across material ESG drivers.
Score Driver: Limited ESG Disclosure Relative To Peers
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Indaptus Therapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
